[Influenza]

Overview

Journal Internist (Berl)

Specialty General Medicine

Date 2019 Sep 4

PMID 31478058

Citations 11

Authors

C Malainou

S Herold

Affiliations

Soon will be listed here.

Abstract

Background: The influenza virus (IV)-associated mortality and morbidity remains high in Europe.

Objective: This article gives an overview of the pathogenesis, diagnostics and treatment optimization strategies according to the currently existing guidelines and clinical trials.

Material And Methods: Literature search and analysis of national and international guidelines for the epidemiology, diagnostics, treatment and prevention of IV infections.

Results And Conclusion: Although the incidence of IV infections remains underrecognized, it is the leading infectious disease-associated cause of mortality and morbidity in Europe. Viruses are mainly transmitted by aerosol inhalation and can cause a wide spectrum of symptoms, ranging from mild signs of a cold to severe respiratory failure requiring mechanical ventilation. The clinical diagnosis should be verified through a PCR-based test in patients with indications for treatment. Neuraminidase inhibitors are currently the treatment of choice for IV infections. Seasonal influenza vaccination is an efficient preventive method. It is therefore imperative to improve vaccination rates in Germany, which have been continuously declining since the pandemic of 2009/2010.

Citing Articles

Beneficial effect of sequential treatment with high-dose steroids and short-course oral glucocorticoids in patients with severe influenza virus-associated pneumonia.

Li W, Gao M, Hao Y, Chi H, Yu J Sci Rep. 2024; 14(1):25023.

PMID: 39443650 PMC: 11499680. DOI: 10.1038/s41598-024-76400-2.

Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.

Schmitt C, Hoefsmit E, Fangmeier T, Kramer N, Kabakci C, Vera Gonzalez J Cancer Immunol Immunother. 2023; 72(11):3475-3489.

PMID: 37606856 PMC: 10576679. DOI: 10.1007/s00262-023-03498-0.

The Effect of Drugs with α-Glutamyl-Tryptophan for Cytokine Secretion and Level of Surface Molecule ICAM-1 In Vitro.

Golovacheva E, Starikova E, Kudryavtseva T, Apryatina V Cell tissue biol. 2023; 17(2):146-152.

PMID: 37131521 PMC: 10134718. DOI: 10.1134/S1990519X23020050.

Subacute thyroiditis presenting as simple acute headache was misdiagnosed as meningitis: case report and literature review.

Huang C, Shen S, Yao J BMC Endocr Disord. 2023; 23(1):53.

PMID: 36879275 PMC: 9990344. DOI: 10.1186/s12902-023-01313-6.

Chest multidetector computed tomography imaging of COVID-19 pneumonia patients with hematologic malignancies.

El-Badrawy A, Elbadrawy N Blood Res. 2022; 57(3):216-222.

PMID: 35920093 PMC: 9492526. DOI: 10.5045/br.2022.2022085.

References

Tellier R . Review of aerosol transmission of influenza A virus. Emerg Infect Dis. 2007; 12(11):1657-62. PMC: 3372341. DOI: 10.3201/eid1211.060426. View

Peteranderl C, Herold S, Schmoldt C . Human Influenza Virus Infections. Semin Respir Crit Care Med. 2016; 37(4):487-500. PMC: 7174870. DOI: 10.1055/s-0036-1584801. View

Yamayoshi S, Kawaoka Y . Current and future influenza vaccines. Nat Med. 2019; 25(2):212-220. DOI: 10.1038/s41591-018-0340-z. View

Jain S, Self W, Wunderink R, Fakhran S, Balk R, Bramley A . Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5):415-27. PMC: 4728150. DOI: 10.1056/NEJMoa1500245. View

Jefferson T, Jones M, Doshi P, Del Mar C, Hama R, Thompson M . Neuraminidase inhibitors for preventing and treating influenza in adults and children. Cochrane Database Syst Rev. 2014; (4):CD008965. PMC: 6464969. DOI: 10.1002/14651858.CD008965.pub4. View

Neumann G, Noda T, Kawaoka Y . Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature. 2009; 459(7249):931-9. PMC: 2873852. DOI: 10.1038/nature08157. View

Kwong J, Schwartz K, Campitelli M, Chung H, Crowcroft N, Karnauchow T . Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med. 2018; 378(4):345-353. DOI: 10.1056/NEJMoa1702090. View

Ambrose C, Levin M . The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012; 8(1):81-8. PMC: 3350141. DOI: 10.4161/hv.8.1.17623. View

Casado I, Dominguez A, Toledo D, Chamorro J, Astray J, Egurrola M . Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study. CMAJ. 2018; 190(1):E3-E12. PMC: 5760253. DOI: 10.1503/cmaj.170910. View

10.

Ruf B, Knuf M . The burden of seasonal and pandemic influenza in infants and children. Eur J Pediatr. 2013; 173(3):265-76. PMC: 3930829. DOI: 10.1007/s00431-013-2023-6. View

11.

Louie J, Yang S, Acosta M, Yen C, Samuel M, Schechter R . Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin Infect Dis. 2012; 55(9):1198-204. DOI: 10.1093/cid/cis636. View

12.

van Houten C, de Groot J, Klein A, Srugo I, Chistyakov I, de Waal W . A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study. Lancet Infect Dis. 2016; 17(4):431-440. DOI: 10.1016/S1473-3099(16)30519-9. View

13.

Lehners N, Tabatabai J, Prifert C, Wedde M, Puthenparambil J, Weissbrich B . Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders. PLoS One. 2016; 11(2):e0148258. PMC: 4750950. DOI: 10.1371/journal.pone.0148258. View

14.

Weinberger D, Harboe Z, Viboud C, Krause T, Miller M, Molbak K . Pneumococcal disease seasonality: incidence, severity and the role of influenza activity. Eur Respir J. 2013; 43(3):833-41. DOI: 10.1183/09031936.00056813. View

15.

Oved K, Cohen A, Boico O, Navon R, Friedman T, Etshtein L . A novel host-proteome signature for distinguishing between acute bacterial and viral infections. PLoS One. 2015; 10(3):e0120012. PMC: 4364938. DOI: 10.1371/journal.pone.0120012. View

16.

von Baum H, Schweiger B, Welte T, Marre R, Suttorp N, Pletz M . How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia. Eur Respir J. 2010; 37(5):1151-7. DOI: 10.1183/09031936.00037410. View

17.

Brandes M, Klauschen F, Kuchen S, Germain R . A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell. 2013; 154(1):197-212. PMC: 3763506. DOI: 10.1016/j.cell.2013.06.013. View

18.

Pauly M, Procario M, Lauring A . A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses. Elife. 2017; 6. PMC: 5511008. DOI: 10.7554/eLife.26437. View

19.

Lim H, Huang S, Chen J, Kerner G, Gilliaux O, Bastard P . Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med. 2019; 216(9):2038-2056. PMC: 6719423. DOI: 10.1084/jem.20181621. View

20.

Cheng Z, Zhou J, To K, Chu H, Li C, Wang D . Identification of TMPRSS2 as a Susceptibility Gene for Severe 2009 Pandemic A(H1N1) Influenza and A(H7N9) Influenza. J Infect Dis. 2015; 212(8):1214-21. PMC: 7107393. DOI: 10.1093/infdis/jiv246. View